Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
Boon
T
T
Cellular Genetics Unit, Ludwig Institute for Cancer Research, Brussels, Belgium.
Coulie
P
P
Marchand
M
M
Weynants
P
P
Wölfel
T
T
Brichard
V
V
D000595:Amino Acid Sequence; D000818:Animals; D000951:Antigens, Neoplasm / Q000235:genetics* / Q000276:immunology; D015234:HLA-A Antigens / Q000235:genetics; D006801:Humans; D007111:Immunity, Cellular; D007157:Immunologic Surveillance; D007167:Immunotherapy; D012515:Mast-Cell Sarcoma / Q000139:chemically induced / Q000235:genetics / Q000276:immunology; D008545:Melanoma / Q000276:immunology / Q000628:therapy; D058950:Melanoma-Specific Antigens; D051379:Mice; D008811:Mice, Inbred DBA; D008969:Molecular Sequence Data; D005810:Multigene Family; D009363:Neoplasm Proteins; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014611:Vaccination
D000951:Antigens, Neoplasm; D015234:HLA-A Antigens; C072011:MAGEA1 protein, human; C489518:Mageb1 protein, mouse; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D011948:Receptors, Antigen, T-Cell